Ticker Details
Guardant Health, Inc.
IPO Date:	October 1, 2018
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$11.43B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.72 | 2.76%
Avg Daily Range (30 D):	$2.55 | 2.84%
Avg Daily Range (90 D):	$2.41 | 2.42%

Institutional Daily Volume
Avg Daily Volume:	1.34M
Avg Daily Volume (30 D):	1.64M
Avg Daily Volume (90 D):	1.69M

Trade Size
Avg Trade Size (Sh.):	68
Avg Trade Size (Sh.) (30 D):	56
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	8,740
Avg Institutional Trade:	$3.34M
Avg Institutional Trade (30 D):	$5.17M
Avg Institutional Trade (90 D):	$5.82M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$7.6M
Avg Closing Trade (30 D):	$21.87M
Avg Closing Trade (90 D):	$21.26M
Avg Closing Volume:	138.09K

News

Mar 30, 2026 @ 8:58 AM Oncology Biomarkers Market Trends and Investment O... Source: Researchandmarkets.Com

Mar 13, 2026 @ 1:23 PM Biotech Stock Up 685% Draws $80.5 Million Investme... Source: Jonathan Ponciano

Jan 22, 2026 @ 5:51 PM FDA Approves Guardant Health's Blood Test To Guide... Source: Vandana Singh

Jan 16, 2026 @ 10:58 AM Global Pan-Genomic and Multi-Gene Panel Testing Ma... Source: Analystview Market Insights

Dec 28, 2025 @ 8:11 PM Why a Top Biotech Holder Sold 115,000 Mirum Shares... Source: Jonathan Ponciano

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.32		$-3.32
Diluted EPS	$-3.32		$-3.32
Revenue	$982.02M		$982.02M
Gross Profit	$633.01M		$633.01M
Net Income / Loss	$-416.28M		$-416.28M
Operating Income / Loss	$-437.25M		$-437.25M
Cost of Revenue	$349.01M		$349.01M
Net Cash Flow	$-140.83M		$-140.83M
PE Ratio